Teriparatide Topical Delivery Supports Osseointegration in Ovariectomized Rats Receiving Cafeteria Diet and Bisphosphonate: An In Vivo Experimental Study
Clinical Oral Implants Research · 26.10.2026
DOI: 10.1111/clr.70187 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Oral Implants Research, online erschienen am 26.10.2026. Verfasst von Ana Cláudia Ervolino da Silva und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Diagnosis and Surgery, São Paulo State University (UNESP), School of Dentistry, Araçatuba, SP, Brazil. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação de Amparo à Pesquisa do Estado de São Paulo, INCT Saúde Oral e Odontologia.
Abstract (Originalsprache)
Background
Postmenopausal osteoporosis associated with cafeteria diet and bisphosphonate therapy may impair peri‐implant bone repair. Therefore, strategies to enhance osseointegration are needed.
Aim
This study investigated whether teriparatide‐coated implant surfaces enhance osseointegration in a rodent model of estrogen deficiency (OVX) and cafeteria diet (CD) treated with risedronate (RIS). Material and Methods In the in vitro phase, titanium discs coated with 10 or 40 ng of teriparatide were evaluated by in vitro bioassays, and drug adsorption was confirmed by UV–Vis spectroscopy. As both loading amounts produced similar biological responses, 10 ng was selected for the in vivo phase. In the in vivo phase, 48 rats were randomly assigned to SHAM (sham‐operated control), OVX/CD (ovariectomized with cafeteria diet), or OVX/CD/RIS (ovariectomized with cafeteria diet and risedronate) groups. Titanium implants either coated with teriparatide using a layer‐by‐layer topical drug delivery system or left non‐coated were placed bilaterally in the maxilla. Rats were euthanized after 28 days. Osseointegration was evaluated by removal torque testing, micro computed tomography, fluorescence microscopy, and RT‐qPCR analysis.
Results
In the cell culture experiment, both teriparatide amounts successfully promoted mineralized nodule formation in vitro and UV–Vis spectroscopy confirmed drug adsorption. In vivo, teriparatide significantly increased removal torque across all groups, with the greatest increase in OVX/CD/RIS. Teriparatide also increased peri‐implant bone volume in OVX/CD and OVX/CD/RIS, confirmed by micro computed tomography and fluorescence microscopy. RT‐qPCR also confirmed upregulation of osteogenic and angiogenic markers.
Conclusion
Topical teriparatide delivery improves peri‐implant bone repair under estrogen deficiency, cafeteria diet, and bisphosphonate therapy.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Diagnosis and Surgery, São Paulo State University (UNESP), School of Dentistry, Araçatuba, SP, Brazil.
- Department of Biosciences and Oral Diagnosis, São Paulo State University (UNESP), Institute of Science and Technology, São José dos Campos, SP, Brazil.
- Department of Basic Sciences, São Paulo State University (UNESP), School of Dentistry, Araçatuba, SP, Brazil.
- Department of Oral Biology, University Clinic of Dentistry, Medical University of Vienna, Vienna, Austria.
- Department of Physics and Meteorology, São Paulo State University (UNESP), School of Science, Bauru, SP, Brazil.
ORCID-Profile: Fábio Roberto de Souza Batista, Naara Gabriela Monteiro, Gabriel Mulinari-Santos, Reinhard Gruber, Paulo Noronha Lisboa-Filho, Roberta Okamoto
Förderung
- Fundação de Amparo à Pesquisa do Estado de São Paulo
- INCT Saúde Oral e Odontologia
Zitieren
APA
da Silva, A. C. E., Batista, F. R. S., Hassumi, J. S., Monteiro, N. G., Fernandes, M. S., Vasconcellos, L. M. R., Mulinari-Santos, G., Gruber, R., Lisboa-Filho, P. N., & Okamoto, R. (2026). Teriparatide Topical Delivery Supports Osseointegration in Ovariectomized Rats Receiving Cafeteria Diet and Bisphosphonate: An In Vivo Experimental Study. Clinical Oral Implants Research. https://doi.org/10.1111/clr.70187
Vancouver
da Silva ACE, Batista FRS, Hassumi JS, Monteiro NG, Fernandes MS, Vasconcellos LMR, et al. Teriparatide Topical Delivery Supports Osseointegration in Ovariectomized Rats Receiving Cafeteria Diet and Bisphosphonate: An In Vivo Experimental Study. Clinical Oral Implants Research. 2026. doi:10.1111/clr.70187
BibTeX
@article{daSilva2026,
author = {da Silva, Ana Cláudia Ervolino and Batista, Fábio Roberto de Souza and Hassumi, Jaqueline Suemi and Monteiro, Naara Gabriela and Fernandes, Marina Santos and Vasconcellos, Luana Marotta Reis and Mulinari-Santos, Gabriel and Gruber, Reinhard and Lisboa-Filho, Paulo Noronha and Okamoto, Roberta},
title = {Teriparatide Topical Delivery Supports Osseointegration in Ovariectomized Rats Receiving Cafeteria Diet and Bisphosphonate: An In Vivo Experimental Study},
journal = {Clinical Oral Implants Research},
year = {2026},
doi = {10.1111/clr.70187}
}
EUVIMED